Herman Waldmann
32Patents
15h-index
30Co-inventors
81Inventor score
Filing activity: Mar 21, 1988 → Nov 23, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5585097A | Humanized anti-CD3 specific antibodies | Chemistry; Metallurgy | 169 | Expired |
| US5502167A | CDR grafted humanised chimeric T-cell antibodies | Emerging Cross-Sectional Technologies | 134 | Expired |
| US5997867A | Method of using humanized antibody against CD18 | Emerging Cross-Sectional Technologies | 108 | Expired |
| US6706265B1 | Humanized anti-CD3 specific antibodies | Chemistry; Metallurgy | 105 | Expired |
| US5968509A | Antibodies with binding affinity for the CD3 antigen | Chemistry; Metallurgy | 96 | Expired |
| US6120766A | CDW52-specific antibody for treatment of multiple sclerosis | Human Necessities | 90 | Expired |
| US7465790B2 | Therapeutic antibodies | Chemistry; Metallurgy | 61 | Expired |
| US7993641B2 | Methods of treatment using anti-CD3 antibodies | Chemistry; Metallurgy | 48 | Active |
| US5846534A | Antibodies to the antigen campath-1 | Chemistry; Metallurgy | 38 | Expired |
| US5985279A | Humanized antibody against CD18 | Emerging Cross-Sectional Technologies | 30 | Expired |
| US6569430B1 | Antibodies to the antigen Campath-1 | Chemistry; Metallurgy | 27 | Expired |
| US6056956A | Non-depleting anti-CD4 monoclonal antibodies and tolerance induction | Human Necessities | 26 | Expired |
| US5690933A | Monoclonal antibodies for inducing tolerance | Human Necessities | 25 | Expired |
| US7247480B2 | Method for producing dendritic cells | Chemistry; Metallurgy | 23 | Expired |
| US7994289B2 | Humanized anti-CD3 antibodies | Chemistry; Metallurgy | 18 | Expired |
| US6689869B2 | Labeled humanized anti-CD18 antibodies and fragments and kits comprising same | Emerging Cross-Sectional Technologies | 15 | Expired |
| US6767996B1 | Altered antibodies and their preparation | Chemistry; Metallurgy | 13 | Expired |
| US8440190B2 | Antibody variants | Chemistry; Metallurgy | 3 | Active |
| US7781213B2 | Method for producing dendritic cells | Chemistry; Metallurgy | 3 | Active |
| US8232100B2 | Method for producing dendritic cells | Chemistry; Metallurgy | 3 | Active |
| US8921104B2 | Method for producing dendritic cells | Chemistry; Metallurgy | 2 | Active |
| USRE43898E1 | Altered antibodies and their preparation | General | 2 | Expired |
| US7098006B1 | Chimeric antibody, pharmaceutical composition and process of its production | Chemistry; Metallurgy | 1 | Expired |
| US7473556B2 | Method for producing dendritic cells | Chemistry; Metallurgy | 1 | Active |
| USRE46877E1 | Altered antibodies and their preparation | General | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.